ALLMedicine™ Hematopoietic Stem Cell Transplantation Center
Research & Reviews 6,304 results
Leukemia & Lymphoma; Waksal JA, Harrison CN et. al.
Dec 3rd, 2021 - Myelofibrosis is a myeloproliferative neoplasm characterized by clonal proliferation of myeloid cells, bone marrow fibrosis and cytopenias, extramedullary hematopoiesis and hepatosplenomegaly, increased pro-inflammatory cytokine production, and sy...
https://doi.org/10.1007/s00404-021-06330-1 10.1056/NEJM195709122571102 10.1056/NEJMra052638 10.1016/j.htct.2018.06.005 10.1016/S0301-472X(00)00677-9 10.1016/j.bbmt.2014.12.001 10.1016/S0140-6736(09)60237-3 10.1016/j.bbmt.2016.09.023 10.1200/JCO.1922.214.171.1243 10.1093/rheumatology/keg025 10.1111/j.1365-2141.2012.09131.x 10.1186/s13048-016-0279-y 10.1201/b21296 10.1201/9780429258589 10.1016/j.bbmt.2014.02.016 10.1111/aogs.13366 10.1016/j.bbmt.2015.09.021 10.1038/sj.bmt.1705487 10.1007/s00277-020-04034-1 10.1097/01.AOG.0000285998.75450.86 10.1038/bmt.2016.150 10.1038/bmt.2013.211 10.1200/JCO.2015.65.8864 10.1016/j.contraception.2012.05.008 10.1177/1933719118799203 10.1200/JCO.2011.34.6890 10.1007/s10147-018-1252-0 10.1053/j.seminhematol.2011.10.002
Archives of Gynecology and Obstetrics; Machado AMN, Rodrigues M et. al.
Dec 3rd, 2021 - Graft-versus-host disease (GVHD) is the main complication of allogeneic hematopoietic stem cell transplantation (HSCT). GVHD in the female genital tract can cause sinusorrhagia, dyspareunia, synechia, and even complete vagina occlusion. This prosp...
https://doi.org/10.1007/s00277-021-04721-7 10.1016/j.medcli.2018.05.013 10.1007/978-1-4939-7299-9_4 10.1097/01.mph.0000175409.21342.ea 10.1080/03630260701459408 10.1016/j.mcna.2016.09.008 10.1182/blood.V88.1.341.341 10.1101/cshperspect.a011858
Annals of Hematology; Li S, Chen K et. al.
Dec 2nd, 2021 - HBB gene mutations lead to many kinds of diseases, of which, except for the two most common diseases of thalassemia and sickle cell anemia, rare kinds of hemolytic anemia, such as hemoglobin Bristol-Alesha, are rarely reported, no ideal treatment ...
The Pediatric Infectious Disease Journal; Nazir HF, Hassanein N et. al.
Dec 1st, 2021 - Little is known about viral-associated hemophagocytic lymphohistiocytosis (HLH) in Oman. This study was done to assess the epidemiology, clinical features and outcome of viral-associated HLH in our setting. We retrospectively reviewed children (0-...
Expert Review of Hematology; Yao Y, Tang Y et. al.
Dec 1st, 2021 - Thrombocytopenia is a tough complication after hematopoietic stem cell transplantation (HSCT) with elusive pathogenesis and lack of well-established therapies. Thrombopoietin receptor agonists (TPO-RAs) have been used for thrombocytopenia post HSC...
Guidelines 15 results
Blood Advances; Kanter J, Liem RI et. al.
Sep 29th, 2021 - Sickle cell disease (SCD) is a life-limiting inherited hemoglobinopathy that results in significant complications and affects quality of life. Hematopoietic stem cell transplantation (HSCT) is currently the only curative intervention for SCD; howe...
Transplantation Bonifazi F, Sica S et. al.
Dec 5th, 2020 - Variation in clinical practice affects veno-occlusive disease management, mainly in patients who undergo allogeneic hematopoietic stem cell transplantation. Disputes about diagnostic criteria, treatment, and prophylaxis, due to the lack of high-qu...
Clinics and Research in Hepatology and Gastroenterology; de Lédinghen V, Villate A et. al.
Apr 8th, 2020 - Sinusoidal obstruction syndrome (SOS), previously known as veno-occlusive disease, is characterized by concentric and non-thrombotic obstruction of the sinusoid and central vein lumen with no identified primitive or thrombotic hepatic vein lesions...
Haematologica Tissot F, Agrawal S et. al.
Dec 25th, 2016 - The European Conference on Infections in Leukemia (ECIL) provides recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various types of infection in patients with hematologic malignancies or he...
Bone Marrow Transplantation; Peffault de Latour R, Peters C et. al.
Jun 9th, 2015 - Allogeneic hematopoietic stem cell transplantation (HSCT) offers the potential to cure patients with an inherited bone marrow failure syndrome (IBMFS). However, the procedure involves the risk of treatment-related mortality and may be associated w...
Drugs 12 results see all →
Clinicaltrials.gov 338 results
Nov 25th, 2021 - To provide the IRB approved mechanism for the prospective collection, analysis and reporting of data on patients who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is...
Nov 25th, 2021 - This is a randomized study to evaluate the safety and feasibility of early de-escalation treatment of empyrical antibiotics treatment in neutropenic fever patients undergoing hematopoietic stem cell transplantation (HSCT). All patients undergoing ...
Nov 24th, 2021 - Background Mutations in the Dedicator of Cytokinesis-8 (DOCK8) gene are responsible for an immunodeficiency disease characterized by: severe cutaneous and sinopulmonary infections with bacterial organisms; extensive cutaneous viral infections with...
Nov 24th, 2021 - This is a Phase II, open-label, multicenter, prospective study of MGTA-145 + plerixafor mobilized HLA-matched sibling and matched unrelated donor allografts for myeloablative hematopoietic stem cell transplantation (HSCT) in recipients with hemato...
Nov 24th, 2021 - RSV is recognized as major respiratory pathogen in infants and young children and causes upper and lower respiratory illness among all age groups, often going undiagnosed. Immunocompromised (IC) participants have a reduced ability to combat infect...
News 250 results
Javier Pinilla-Ibarz MD, PhD
Nov 2nd, 2021 - Javier Pinilla-Ibarz MD, PhD In the new era of the COVID-19 pandemic, patients and physicians still struggle to see how different hematologic conditions may be affected by this viral infection. Although it has been well reported that COVID-19 may.
Oct 24th, 2021 - Key clinical point: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the first complete remission (CR1) after intensive chemotherapy (IC) offered clinical benefits in elderly patients with intermediate- or unfavorable-risk acute m.
Oct 6th, 2021 - Stephen M. Ansell, MD, PhD Checkpoint inhibitors are making their way through the treatment paradigm of lymphomas with 2 FDA approvals in the last year. Now, combinations are likely next, as early results demonstrate encouraging activity across v...
Sep 26th, 2021 - Key clinical point: Enasidenib was associated with superior overall survival (OS) compared to standard of care (SoC) therapies in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) with an isocitrate dehydrogenase 2 ( IDH2) mutat.
Sep 2nd, 2021 - Regimens that included the off-the-shelf, induced pluripotent stem cell (iPSC)–derived natural killer (NK) cell products FT596 and FT516 were found to elicit encouraging responses with favorable tolerability when used in patients with B-cell lymph...